NHS England Midlands Cancer Alliance announces new Chair, David Loughton

David Loughton, CBE has been announced as the new Chair of the West Midlands Cancer Alliance. David is the longest serving Chief Executive in the NHS, having been a CEO for 31 years. He joined the board of the Cancer Alliance in December 2017.

The West Midlands Cancer Alliance provides leadership to improve cancer patient’s outcomes both in terms of survival and experience of care. This extends from prevention strategies, through screening and early diagnosis, delivery of evidence based treatment, living with and beyond cancer, palliative and supportive care to end of life care. The Alliance in the West Midlands was established in 2016 to provide leadership and ensure successful delivery of the Alliance’s programme of work, including overseeing that local plans are aligned and support STP and transformation across the West Midlands. It is the decision-making body in relation to the planning and delivery of the Cancer Task force strategy across the West Midlands.

David started his career in the NHS in 1986. He is currently Chief Executive of The Royal Wolverhampton NHS Trust a role which he has held since joining the Trust in 2004. He has overseen the financial turnaround at the Trust, whilst improving the quality of care provided to patients.

Mr Loughton is also a member of the National Institute for Health Research Advisory Board.

David said: “I am delighted and honoured to be appointed Chair of the West Midlands Cancer Alliance.  These are challenging times for the NHS, and I am looking forward to working with the team to ensure that the best cancer services are provided from the most appropriate locations for people across the West Midlands.”

Dr Andrea Gordon, Programme Director, West Midlands Cancer Alliance, added: “David brings a wealth of experience and knowledge about the NHS to this role. His extensive skills, knowledge and experience will, I am sure, enable him to shape the future of high quality and sustainable cancer services for the people in the Midlands. He is a passionate supporter of clinical engagement and digitalisation of pathology services.

“I would also like to take this opportunity to thank Dame Julie Moore for her contribution as our first Chair of the West Midlands Cancer Alliance. Her decision to step-down, follows her announcement, earlier this year, to retire as Chief Executive of University Hospitals Birmingham NHS Foundation Trust.

“I look forward to working with David who I know will help us drive forward our ambitious transformation programme for Cancer Services across the West Midlands.”